Is human hepatocellular carcinoma a hormone-responsive tumor?

Before the positive results recently obtained with multitarget tyrosine kinase inhibitor sorafenib, there was no standard systemic treatment for patients with advanced hepatocellular carcinoma (HCC). Sex hormones receptors are expressed in a significant proportion of HCC samples. Following preclinic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Maio, Massimo Di, Daniele, Bruno, Pignata, Sandro, Gallo, Ciro, Maio, Ermelinda De, Morabito, Alessandro, Piccirillo, Maria Carmela, Perrone, Francesco
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: The WJG Press and Baishideng 2008
Gaiak:
Topic Highlight
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2695908/
https://ncbi.nlm.nih.gov/pubmed/18350599
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.14.1682
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak